Search results for " Local"

showing 10 items of 2101 documents

Epidural ropivacaine -- where are the benefits? A prospective, randomized, double-blind trial in patients with retropubic prostatectomy.

2007

Background:  In comparison with bupivacaine, ropivacaine exhibits comparable anaesthetic effects but with less motor impairment and systemic toxicity. However, the analgesic potency may differ. For example, ropivacaine during obstetric epidural analgesia provides an approximately 40% lower analgesic potency than bupivacaine. Equal visual analogue pain scores require significantly higher dosages of ropivacaine, and general statements about a favourable benefit–risk profile relative to that of bupivacaine may therefore have limited clinical impact. We addressed this topic in a male pain model by evaluating the analgesic efficacy of epidural ropivacaine 0.2% vs. bupivacaine 0.125% after retrop…

Malemedicine.medical_specialtyTime FactorsDosemedicine.drug_classAnalgesicMotor ActivityStatistics NonparametricLumbarDouble-Blind MethodClinical endpointmedicineHumansRopivacaineProspective StudiesEpidural administrationAnesthetics LocalAgedPain MeasurementBupivacaineProstatectomyPain Postoperativebusiness.industryRopivacaineLocal anestheticAnalgesia Patient-ControlledGeneral MedicineMiddle AgedAmidesBupivacaineSurgeryAnalgesia EpiduralAnesthesiology and Pain MedicinePatient SatisfactionAnesthesiabusinessmedicine.drugActa anaesthesiologica Scandinavica
researchProduct

Comparison between local and regional anesthesia in arteriovenous fistula creation.

2011

Purpose Assessment of the effectiveness of Brachial Plexus Block (BPB) via axillary approach compared to regional anesthesia for arteriovenous fistula surgery in patients affected by end-stage renal disease. Methods We compared forty patients randomly divided into two groups. Group A underwent BPB procedure with 15 mL ropivacaine 1% and 10 mL of saline (0.9% NaCl) via axillary approach. Group B received local anesthesia with lidocaine 2%. The forearm blood vessels were assessed by Doppler ultrasonography before and after the intervention. Results BPB performed on Group A was associated with a considerable venous dilation and a significant decrease (48.7%, P<.05) in pulsatility index (PI)…

Malemedicine.medical_specialtyTime Factorslocal and regional anesthesiaFistulaArteriovenous fistulaSettore MED/41 - AnestesiologiaVeinsArteriovenous Shunt SurgicalForearmRenal DialysisOcclusionmedicineHumansLocal anesthesiaBrachial PlexusRopivacaineAnesthetics Localarteriovenous fistulaBrachial plexus blockarteriovenous fistula; local and regional anesthesiaAgedRopivacainebusiness.industryLidocaineNerve BlockUltrasonography DopplerMiddle Agedmedicine.diseaseThrombosisAmidesSurgeryVasodilationSettore MED/18 - Chirurgia GeneraleForearmmedicine.anatomical_structureTreatment OutcomeItalyNephrologyAnesthesiaRadial ArteryKidney Failure ChronicSurgeryFemalebusinessmedicine.drugAnesthesia LocalThe journal of vascular access
researchProduct

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent…

2015

Summary Background Acute myeloid leukaemia mainly affects elderly people, with a median age at diagnosis of around 70 years. Although about 50–60% of patients enter first complete remission upon intensive induction chemotherapy, relapse remains high and overall outcomes are disappointing. Therefore, effective post-remission therapy is urgently needed. Although often no post-remission therapy is given to elderly patients, it might include chemotherapy or allogeneic haemopoietic stem cell transplantation (HSCT) following reduced-intensity conditioning. We aimed to assess the comparative value of allogeneic HSCT with other approaches, including no post-remission therapy, in patients with acute…

Malemedicine.medical_specialtyTransplantation ConditioningGemtuzumab ozogamicinmedicine.medical_treatmentAntibodies Monoclonal HumanizedCOUNCIL AML11 TRIALEUROPEAN LEUKEMIANETInternal medicinehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointINDUCTION CHEMOTHERAPYHumansTransplantation HomologousProspective StudiesADULT PATIENTS610 Medicine & healthBusulfanMETAANALYSISAgedMYELODYSPLASTIC SYNDROMEChemotherapyRISK-ADAPTED APPROACHbusiness.industryRemission InductionHematopoietic Stem Cell TransplantationInduction chemotherapyHematology1ST COMPLETE REMISSIONTotal body irradiationMiddle AgedGemtuzumabGEMTUZUMAB OZOGAMICINSurgeryFludarabineTransplantationSurvival RateLeukemia Myeloid AcuteAminoglycosidesTreatment OutcomeSURVIVALFemaleNeoplasm Recurrence LocalbusinessBusulfanVidarabinemedicine.drugLancet. Haematology
researchProduct

CT after enucleation of renal cell carcinoma.

1994

Computed tomography (CT) was performed in 28 patients 2 weeks to 120 months after enucleation of renal cell carcinoma. The postoperative defect could be exactly localized in all patients. A wedge-shaped (N = 11) or concave (N = 9) morphology was typical. No dependence between morphology of the defect and localization or size of the tumor or the operative technique was observed. The defects were smaller (1.9 cm) than the original prominent tumors (3.6 cm). Defect size was dependent on the operative technique: closure by suture of the renal capsule in smaller defects or by fat flap in larger ones. Postoperative hematomas or delayed perfusion in the adjacent parenchyma were seen in five patien…

Malemedicine.medical_specialtyUrologyEnucleationDiagnosis DifferentialPostoperative ComplicationsSuture (anatomy)Renal capsuleRenal cell carcinomaParenchymaMedicineHumansRadiology Nuclear Medicine and imagingCarcinoma Renal CellKidneyRadiological and Ultrasound Technologybusiness.industryGastroenterologyKidney NeoplasmMiddle Agedmedicine.diseaseKidney Neoplasmsmedicine.anatomical_structureFemaleRadiologyNeoplasm Recurrence LocalbusinessTomography X-Ray ComputedPerfusionAbdominal imaging
researchProduct

Urethral Tumor Recurrences after Radical Cystoprostatectomy: The Case for Primary Cystoprostatourethrectomy?

1990

Of 273 male patients who underwent radical cystoprostatectomy between 1967 and 1987, 22 were regarded as at risk for urethral recurrence. These patients underwent simultaneous primary urethrectomy or urethrectomy shortly after cystectomy because of the histology of the cystectomy specimen. Of the remaining 251 patients a urethral recurrence was observed in 23 (9.2%). A patient with a urethral recurrence originally had undergone an operation at another hospital. The first urethral tumor recurrence was observed in 1977 but between October 1987 and May 1988, 7 patients were treated for an initial or secondary urethral recurrence. This finding suggests that the rate of urethral recurrence incre…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyCystoprostatectomyCystectomyUrethraUrethrectomymedicineCarcinomaHumansProstatectomyUrethral NeoplasmsEpitheliomaRadical cystoprostatectomybusiness.industryProstatectomymedicine.diseaseSurgeryUrethramedicine.anatomical_structureUrinary Bladder NeoplasmsNeoplasm Recurrence LocalbusinessJournal of Urology
researchProduct

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.

2005

OBJECTIVES To report the long-term follow-up of patients with locally advanced bladder cancer treated with either adjuvant combined chemotherapy with methotrexate, vinblastine, doxorubicin/epirubicin, and cisplatin (MVAC/MVEC) or no additional treatment after radical cystectomy, to examine various survival endpoints and factors associated with long-term survival. PATIENTS AND METHODS Between May 1987 and December 1990, 49 patients undergoing radical cystectomy for locally advanced bladder cancer were randomized to observation only or adjuvant systemic chemotherapy with three cycles of MVAC/MVEC (methotrexate 30 mg/m2 on day 1, 15 and 22; vinblastine 3 mg/m2 on day 2, 15 and 22; doxorubicin …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastineDisease-Free SurvivalCystectomyAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansAgedEpirubicinChemotherapyBladder cancerbusiness.industryHazard ratioCombination chemotherapyMiddle Agedmedicine.diseaseInterim analysisCombined Modality TherapyVinblastineSurgeryMethotrexateTreatment OutcomeUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinLymphatic MetastasisFemaleCisplatinNeoplasm Recurrence Localbusinessmedicine.drugEpirubicinFollow-Up StudiesBJU international
researchProduct

Postoperative analgesic efficacy of peripheral levobupivacaine and ropivacaine: a prospective, randomized double-blind trial in patients after total …

2008

BACKGROUND: Several previous trials have characterized the intra- and postoperative effects of the recently introduced local anesthetics, levobupivacaine and ropivacaine, for a variety of continuous peripheral nerve blocks. METHODS: We compared the analgesic efficacy of levobupivacaine 0.125% versus ropivacaine 0.2% via patient-controlled femoral nerve analgesia after total knee arthroplasty. In a double-blind, randomized, prospective design, 60 patients received femoral infusion with either substance. We analyzed postoperative local anesthetic consumption, pain scores, motor block, and opioid requirements over 72 h. RESULTS: Pain scores, motor block incidence, and opioid requirements were …

Malemedicine.medical_specialtymedicine.drug_classAnalgesicTotal knee arthroplastyWalkingFemoral nerveDouble-Blind MethodMedicineHumansRopivacaineProspective StudiesAnesthetics LocalArthroplasty Replacement KneeAgedLevobupivacainePain MeasurementAged 80 and overPain Postoperativebusiness.industryLocal anestheticRopivacaineAnalgesia Patient-ControlledNerve BlockMiddle AgedAmidesBupivacainePeripheralSurgeryAnalgesics OpioidAnesthesiology and Pain MedicineTreatment OutcomeOpioidLevobupivacainePatient SatisfactionAnesthesiaFemalebusinessFemoral Nervemedicine.drugAnesthesia and analgesia
researchProduct

Hemodynamic impact of isobaric levobupivacaine versus hyperbaric bupivacaine for subarachnoid anesthesia in patients aged 65 and older undergoing hip…

2014

Background The altered hemodynamics, and therefore the arterial hypotension is the most prevalent adverse effect after subarachnoid anesthesia. The objective of the study was to determine the exact role of local anesthetic selection underlying spinal anesthesia-induced hypotension in the elderly patient. We conducted a descriptive, observational pilot study to assess the hemodynamic impact of subarachnoid anesthesia with isobaric levobupivacaine versus hyperbaric bupivacaine for hip fracture surgery. Description Hundred twenty ASA status I-IV patients aged 65 and older undergoing hip fracture surgery were enrolled. The primary objective of our study was to compare hemodynamic effects based …

Malemedicine.medical_specialtymedicine.drug_classSubarachnoid blockHemodynamicsPilot ProjectsSubarachnoid SpaceHip fractureDatabaseElderlyAnesthesiologymedicineHumansOrthopedic ProceduresAnesthetics LocalLevobupivacaineAgedBupivacaineHip surgeryAged 80 and overHip fractureLocal anestheticbusiness.industryHip FracturesHemodynamicsMiddle Agedmedicine.diseaseBupivacaineAnesthesiology and Pain MedicineBlood pressureAtmospheric PressureLevobupivacaineAnesthesiaRespiratory MechanicsFemaleHypotensionbusinessmedicine.drugAnesthesia LocalBMC Anesthesiology
researchProduct

A comparison of the Enk Fiberoptic Atomizer Set(™) with boluses of topical anaesthesia for awake fibreoptic intubation.

2016

We compared the Enk Fiberoptic Atomizer Set(™) with boluses of topical anaesthesia administered via the working channel during awake fibreoptic tracheal intubation in 96 patients undergoing elective surgery. Patients who received topical anaesthesia via the atomiser, compared with boluses via the fibreoptic scope, reported a better median (IQR [range]) level of comfort: 1 (1-3 [1-10]) vs. 4 (2-6 [1-10]), p < 0.0001; experienced a reduced total number of coughs: 6 (3-10 [0-34]) vs. 11 (6-13 [0-25]), p = 0.0055; and fewer distinct coughing episodes: 7% vs. 27% respectively, p = 0.0133. The atomiser technique was quicker: 5 (3-6 [2-12]) min vs. 6 (5-7 [2-15]) min, p = 0.0009; and required less…

Malemedicine.medical_specialtymedicine.medical_treatmentFibreoptic intubation03 medical and health sciences0302 clinical medicineBolus (medicine)030202 anesthesiologyIntubation IntratrachealMedicineFiber Optic TechnologyHumansNasal intubationElective surgeryAnesthetics LocalWakefulnessTopical anaesthesiabusiness.industryNebulizers and VaporizersTracheal intubationLidocaine030208 emergency & critical care medicineMiddle AgedSurgeryTopical lidocaineAnesthesiology and Pain MedicineAnesthesiaFemalebusinessAwake intubationAnaesthesia
researchProduct

Occurrence of rapid eye movement sleep deprivation after surgery under regional anesthesia.

2013

Sleep disturbances after general surgery have been described. In this study, we assessed rapid eye movement (REM) sleep in patients undergoing knee replacement surgery using a regional anesthetic technique.Ambulatory polysomnography (PSG) was performed on 3 nights: the night before surgery (PSG1), the first night after surgery (PSG2), and the fifth postoperative night (PSG3). Postoperative analgesia was maintained with peripheral nerve catheters for the first 3 days and with oral opioids thereafter. In addition, nonsteroidal antiinflammatory drugs were administered. Postoperative pain was monitored using a visual analog scale.PSG was performed in 12 patients, 6 men and 6 women, with a mean …

Malemedicine.medical_specialtymedicine.medical_treatmentPolysomnographyRapid eye movement sleepKnee replacementPilot ProjectsPolysomnographyPostoperative ComplicationsAnesthesia ConductionmedicineHumansAnesthetics LocalArthroplasty Replacement KneeAgedPain MeasurementPain Postoperativemedicine.diagnostic_testbusiness.industryAnti-Inflammatory Agents Non-SteroidalEye movementMiddle AgedSleep in non-human animalsBupivacaineSurgeryAnalgesics OpioidOxygenSleep deprivationAnesthesiology and Pain MedicineAnesthesiaAnestheticAmbulatorySleep DeprivationFemalemedicine.symptombusinessmedicine.drugAnesthesia and analgesia
researchProduct